Literature DB >> 21424606

Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing.

Ching-Yu Huang1, Pei-Lun Sun, Hsiang-Kuang Tseng.   

Abstract

Paecilomyces lilacinus causes multiple diseases in humans, especially in immunocompromised patients. Cutaneous infections are the second most commonly encountered circumstance. We describe a woman with liver cirrhosis with hemorrhagic, bullous, ulcerative leg lesions caused by Paecilomyces lilacinus. The lesions improved after treatment with oral voriconazole and topical nystatin powder. We also reviewed previously reported cases of cutaneous P. lilacinus infection that were treated by oral voriconazole.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424606     DOI: 10.1007/s11046-011-9409-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  14 in total

1.  Paecilomyces lilacinus cutaneous infection associated with a dog bite.

Authors:  Enrico Zendri; Giancarlo Martignoni; Magda Benecchi; Franco Fanti; Giuseppe De Panfilis
Journal:  J Am Acad Dermatol       Date:  2006-08       Impact factor: 11.527

Review 2.  New aspects of emerging fungal pathogens. A multifaceted challenge.

Authors:  W A Schell
Journal:  Clin Lab Med       Date:  1995-06       Impact factor: 1.935

3.  Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion.

Authors:  B Orth; R Frei; P H Itin; M G Rinaldi; B Speck; A Gratwohl; A F Widmer
Journal:  Ann Intern Med       Date:  1996-11-15       Impact factor: 25.391

4.  Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole.

Authors:  I Hilmarsdóttir; S B Thorsteinsson; P Asmundsson; M Bödvarsson; M Arnadóttir
Journal:  Scand J Infect Dis       Date:  2000

Review 5.  Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed.

Authors:  P H Itin; R Frei; S Lautenschlager; S A Buechner; C Surber; A Gratwohl; A F Widmer
Journal:  J Am Acad Dermatol       Date:  1998-09       Impact factor: 11.527

Review 6.  Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosis.

Authors:  Susanna Naggie; John R Perfect
Journal:  Clin Chest Med       Date:  2009-06       Impact factor: 2.878

7.  Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy.

Authors:  Brian Pin-Hsuan Chang; Pei-Lun Sun; Fu-Yuan Huang; Tsuen-Chiuan Tsai; Chun-Chen Lin; Ming-Dar Lee; Yee-Chun Chen; Jin-Cherng Sheu; Jeng-Daw Tsai
Journal:  J Med Microbiol       Date:  2008-12       Impact factor: 2.472

8.  In vitro interactions of approved and novel drugs against Paecilomyces spp.

Authors:  Montserrat Ortoneda; Javier Capilla; F Javier Pastor; Isabel Pujol; Clara Yustes; Carolina Serena; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

9.  Antifungal susceptibilities of Paecilomyces species.

Authors:  C Aguilar; I Pujol; J Sala; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

Review 10.  Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature.

Authors:  T Van Schooneveld; A Freifeld; B Lesiak; A Kalil; D A Sutton; P C Iwen
Journal:  Transpl Infect Dis       Date:  2007-07-01       Impact factor: 2.228

View more
  3 in total

Review 1.  Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voriconazole and review of published literature.

Authors:  Maryam Keshtkar-Jahromi; Arthur H McTighe; Keith A Segalman; Annette W Fothergill; Wayne N Campbell
Journal:  Mycopathologia       Date:  2012-04-08       Impact factor: 2.574

Review 2.  Use of voriconazole for the treatment of Paecilomyces lilacinus cutaneous infections: case presentation and review of published literature.

Authors:  Ramzy H Rimawi; Yvonne Carter; Thomas Ware; John Christie; Dawd Siraj
Journal:  Mycopathologia       Date:  2013-01-20       Impact factor: 2.574

3.  Isavuconazonium for the treatment of Purpureocillium lilacinum infection in a patient with pyoderma gangrenosum.

Authors:  Julia Accetta; Emily Powell; Erin Boh; Lisa Bull; Abida Kadi; Alfred Luk
Journal:  Med Mycol Case Rep       Date:  2020-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.